Supplementary Tables.docx (63.33 kB)
Download fileCell administration routes for heart failure: a comparative re-evaluation of the REGENERATE-DCM and REGENERATE-IHD trials. Supplementary tables
dataset
posted on 2022-10-13, 07:58 authored by Anthony Mathur, John MartinJohn Martin, Thomas Godec, Alice Reid, Jessry Veerapen,, Didier Locca, Ceri Davies, Daniel A. Jones, Doo Sun Sim
Table S1. Baseline characteristics of the REGENERATE-DCM and REGENERATE-IHD trials
Table S2. The characteristics of the cells found in the injectate in the individual trials.
Table S3. The pooled characteristics of the cells found in the peripheral blood and the injectate.
Table S4. Left ventricular ejection fraction and volumes
Table S5. Overview of randomised controlled cell therapy trials for heart failure divided by delivery route.
